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Voltage-Gated Calcium Channel a2d Subunits in Lipid Rafts: The Impor-
tance of Proteolytic Cleavage Into a2 and d
Ivan Kadurin1, Claudia Bauer1, Beatrice Lana1, Anita Alvarez-Laviada1,
Manuela Nieto-Rostro1, Leon Douglas1, Linda Troeberg2, Hideaki Nagase2,
Annette C. Dolphin1.
1University College London, London, United Kingdom, 2Kennedy Institute
of Rheumatology, Oxford University, London, United Kingdom.
The High Voltage-Activated (HVA) subgroup of voltage-gated calcium chan-
nels contain an a1 subunit, which forms the selective pore and determines the
main functional properties of the channel. The a1 subunit is associated with
auxiliary subunits including b and a2d, which modulate trafficking and func-
tional properties of the channels.
There are four known genes encoding a2d subunits, which are believed to have
similar structure. They consist of two peptides: the highly glycosylated a2
which is entirely extracellular is disulfide-bonded to a d subunit that links the
protein into the plasma membrane. The a2 and d peptides are encoded by
a single gene as an uninterrupted a2d pre-protein, which is further processed
post-translationally. We have recently shown that a2d subunits are glycosyl
phophatidyl inositol (GPI)-achored proteins (Davies et al., 2010, PNAS
107:1654-1659), and this is essential for their function, and explains their local-
ization in lipid raft fractions (Davies et al, 2006, J. Neurosci. 26: 8748-8757).
We further studied the mechnism and consequences of the proteolytic cleavage
of the a2d subunits (a2d-1, -2 and -3)and identified the cleavage sites in a2d-2
and a2d-3. Western blots from brain tissue revealed only the mature form of the
protein strongly associated with lipid rafts. However, transfecting mammalian
cells with cDNA for a2d-1,-2,and -3 resulted in incomplete cleavage (~ 40-
60% processing) most probably due to limitations of the cleavage-mediating
protease(s) in heterologous expression systems. The mature form is localized
in lipid rafts, suggesting that maturation of the protein might occur in localized
membrane domains. Moreover, electrophysiological recordings demonstrated
that proteolytic cleavage is key to the function of these subunits.
We are currently examining the nature of the protease(s) involved in this pro-
teolytic processing.
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Calcium Dependent Inactivation of CaV1.1 Channels in Adult Skeletal
Muscle: A Possible Role of RyR1 Channels
Erick O. Herna´ndez-Ochoa, Martin F. Schneider.
University of Maryland, Baltimore, MD, USA.
Ca2þ dependent inactivation (CDI) has been documented for the great major-
ity of voltage dependent Ca2þ channels (Cav) but whether native Cav1.1 of
adult skeletal muscle exhibits this feature remains controversial. When ex-
plored in heterologous (i.e., HEK cells) or homologous expression (i.e., myo-
tubes), systems that lack or display immature E-C coupling, respectively,
several groups have demonstrated both the absence and presence of Cav1.1
CDI. In a recent report using homologous expression system where CDI was
documented, Cav1.1 channels displayed the classical features of CDI: 1) depen-
dence on extracellular Ca2þ, 2) elimination by replacing Ca2þ with Ba2þ or
by using high affinity and fast kinetics Ca2þ buffer BAPTA, and 3) calmodulin
modulation. Here we use whole-cell voltage clamp Ca2þ current recordings
obtained from adult skeletal muscle fibers to address whether Cav1.1 exhibits
CDI in its native environment. Surprisingly, Ca2þ current inactivation was in-
sensitive to Ca2þ substitution by Ba2þ, suggesting that 1) CDI is not present
or 2) that Ca2þ flowing through the channels is not the Ca2þ source for current
inactivation. We tested the hypothesis that Ca2þ release from SR via ortograde
Cav1.1-RyR signaling may be the source for CDI. To test this hypothesis we
use dantrolene (a membrane permeable RyR Ca2þ release channel antagonist).
When 40 mMdantrolene (a concentration that suppress action potential evoked-
Ca2þ transient by ~30%) was added to the external solution Cav1.1 CDI was
partially suppressed. These observations suggest the provocative idea that
Cav1.1 CDI is regulated by Ca2þ release via adjacent sarcoplasmic reticulum
RyR1 channels. Supported by NIH-NIAMS (R01-AR055099).
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CaBP1 and Calmodulin Compete in Regulating Calcium-Dependent
Inactivation of CaV1.2
Shimrit Oz, Adva Benmocha, Nathan Dascal.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
CaV1.2 is an L-type calcium channel from a family of voltage dependent cal-
cium channels (VDCC) distributed mainly in cardiac and smooth muscle, en-
docrine cells and neurons, which produce calcium influx in response to
membrane depolarization. Interaction of calcium binding protein 1 (CaBP1)
and calmodulin (CaM) with the C-terminus (CT) of the L-type CaV1.2 channel
is crucial for calcium-dependent inactivation (CDI); CaBP1 has an oppositeeffect on VDCCs compared to CaM: while CaM promotes CDI, CaBP1 pro-
longs and facilitates calcium currents and does not support CDI. CaBP1 and
CaM are also bind to the N-terminus (NT), but the role of this interactions
and the effect of these proteins on each other are unknown. We characterized
the interaction of CaBP1 with NT peptides of alpha-1C using pull down assay.
This binding site of CaBP1 is between a.a. 95-120 and does not overlap the
CaM binding site; the binding is not calcium dependent. Coexpression of
CaBP1 with CaV1.2 in Xenopus oocytes eliminated the CaM-dependent CDI.
Inversely, titrated expression of fluorescently tagged CaM and CaBP1 showed
that CaM removed the effect of CaBP1 at a molar ratio of ~a 1:1 in the cell. Al-
aninemutagenesis of the CaM binding site and deletion of the NT binding site of
CaBP1 did not remove the effect of CaBP1 on the inactivation. Thus, NT does
not appear to be the important anchoring site for the action CaBP1, and the
role of the interaction of CaBP1 with the CaV1.2 NT remains to be determined.
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Structural Determinants of CaV1.3 L-Type Calcium Channel Gating
Andreas Lieb, Anja Scharinger, Simone Sartori, Alexandra Koschak,
Martina J. Sinnegger-Brauns, Joerg Striessnig.
University of Innsbruck, Innsbruck, Austria.
Cav1.3 L-type Ca
2þ-channels are key signal molecules for hearing, cardiac
pacemaking and neuronal excitability. We have recently discovered a C-termi-
nal intramolecular protein-interaction in Cav1.3 a1-subunits as a gating modi-
fier (CTM). This modulatory domain is absent in short C-terminal splice
variants. Its presence shifts half maximal activation voltage (V0.5) to more pos-
itive potentials and inhibits Ca2þ-dependent-inactivation (CDI). This regula-
tion is present in long variants of human (Singh et al., 2008) and rat cDNA
clones from pancreatic islets (rCav1.3pan) but not in a clone derived from supe-
rior cervical ganglion (rCav1.3scg). rCav1.3scg differs from rCav1.3pan at three
amino acid (aa) positions (S244G, V1104A, A2073V), a polymethionine-
stretch with two additional lysines, and one alternatively spliced locus (exon
31). We took advantage of these discrete differences to determine their role
for the kinetic differences between rCav1.3scg and rCav1.3pan (in voltage-
dependence of activation and CDI) by expressing channel mutants in tsA-
201 cells and whole-cell patch-clamp-recordings.
Two aa (S244, A2073) in rCav1.3scg explained most of the functional differ-
ences to rCav1.3pan. Mutation S244G even further enhanced CDI of rCav1.3scg
and shifted its V0.5 to more positive potentials. A2073V (located within the
CTM) also shifted V0.5 more positive but almost eliminated CDI. The cooper-
ative action in the double-mutant restored gating properties (CDI, V0.5) similar
to rCav1.3pan. Their effects are compatible with a recently proposed allosteric
CDI mechanism implying CaM-mediated inhibition of the activation gate (Ta-
dross and Yue, 2010). Analysis of inactivation kinetics suggest that G244 de-
creases the open probability (Po) of the inactivated gating mode, whereas
A2073V reduces the maximal Po of rCav1.3scg as evident from increased gating
currents.
G244 and V2073 affect CDI through different molecular mechanisms. To-
gether they stabilize the gating behaviour of long CaV1.3 splice variants under-
going C-terminal-modulation.
Support: Austrian Science Fund (F4402, P20670, W11), University of Innsbruck
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A Novel FRET-Based Assay Reveals 1:1 Stoichiometry of Apocalmodulin
Binding Across Voltage-Gated Ca and Na Ion Channels
Manu B. Johny, Daniel N. Yue, David T. Yue.
Johns Hopkins University, Baltimore, MD, USA.
Voltage-gated Ca and Na channels represent two important classes of ion chan-
nels where resident calmodulin (CaM) regulates channel gating, providing the
cell with vital Ca2þ feedback. Functionally, a single CaM has been suggested to
suffice for Ca2þ-modulation of channel gating (Science, 304:432; JGP
131:197). However, in vitro structural and biochemical studies have argued
that multiple Ca2þ/CaMs may bind to the CaV channel carboxy-terminus (pri-
mary locus of CaM/channel interaction). Thus, the stoichiometry of apoCaM
binding to the channel carboxy-terminus remains a crucial unknown. In this re-
gard, live-cell FRET 2-hybrid assay has been used extensively to probe
apoCaM binding. To gauge relative binding affinities, FRET efficiency be-
tween fluorophore-tagged apoCaM and a binding partner may be measured
from acceptor-centric (33-FRET, Neuron39:97) or donor-centric (E-FRET, Bi-
ophys J91:L39) perspectives. Here, we exploit a fundamental asymmetry be-
tween these measures to estimate the stoichiometry of binding between
apoCaM and channel carboxy termini: the ratio of maximal FRET efficiencies,
as measured by 33-FRET and E-FRET methods, will approximate the ratio of
donors to acceptors present in the complex. CFP and YFP concatemers with
known ratios of donors and acceptors confirm this remarkable principle. Ac-
cordingly, we quantified both 33-FRET and E-FRET between CFP-apoCaM
126a Sunday, February 26, 2012and YFP-tagged carboxy-terminal peptides of CaV1.3, CaV2.1, NaV1.4, and
NaV1.5 channels. Remarkably, the maximal FRET ratios, computed via 3
3-
FRET and E-FRETmethods, equaled unity, arguingwell for a 1:1 stoichiometry
of apoCaMbinding across CaV andNaV ion-channel families. These results mir-
ror functional findings that a single CaM, pre-associated to the carboxy-termini
of these channels, suffices for robust modulation of channel gating. More
broadly, these experiments underscore the power of FRET 2-hybrid assay to dis-
cern multiple aspects of binding interactions within a live-cell context.
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Resolving the Grip of the Distal Carboxy Tail on the Proximal Calmodu-
latory Region of CaV Channels
Lingjie Sang, Hojjat Bazzazi, Manu B. Johny, David T. Yue.
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ca2þ/calmodulin-dependent inactivation (CDI) of CaV channels plays a crucial
role in the homeostasis of intracellular Ca2þ, and serves as an ideal prototype
for investigating Ca2þ feedback regulation within biological systems. The pre-
vailing view of CDI mechanism is that Ca2þ-free calmodulin (apoCaM) preas-
sociates with the IQ domain of the proximal carboxy terminus of channels, and
this ‘resident’ calmodulin (CaM) acts as Ca2þ sensor to somehow trigger CDI
upon Ca2þ binding. The downstream CaM/channel configurations leading to
CDI are complex and under investigation at present. Contrasting with this com-
plexity, CaV1.3 and CaV1.4 feature a long-carboxy-tail splice variant that min-
imizes CDI by a beautifully simple mechanism. We recently combined
electrophysiology and a genetically encoded fluorescent sensor to record CDI
and CaM concentration simultaneously (Nature463:968), thereby demonstrat-
ing that the distal-carboxy-tail (DCT) harbors an ICDI module that competes
with apoCaM for binding to the IQ domain. By kicking off apoCaM, ICDI di-
minishes CDI in an eminently straightforward manner; thus, the IQ/ICDI com-
plex now looms as a simplified prototype for novel channel modulators, and as
an easy entrez into complex CaM/channel configurations underlying CDI.
Here, we perform alanine-scanning mutagenesis of the entire IQ domain and
ICDI domain. Hotspot mutations which reduce IQ/ICDI binding affinity also
commensurately diminish ICDI function (i.e., permit restoration of CDI). Fur-
thermore, the ensemble of effects can be well fit with a Michaelis-Menten equa-
tion incorporating the presence of a competitive inhibitor. Thus, the collection
of hotspots can be used to identify the minimal functional segments of IQ/ICDI
interaction to facilitate structure building, and to provide clues for designing
small peptides and/or molecules that regulate CDI of specific CaV channels.
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The Cardiac L-Type Calcium Channel Distal Carboxyl Terminus is
a Reverse use Dependent Inhibitor of Ca Current in Cardiomyocytes
Shawn M. Crump, Jonathan Satin.
University of Kentucky, lexington, KY, USA.
Background. The LTCC distal C-terminus (DCT) is proteolytically cleaved,
and re-associates with the LTCC complex to regulate calcium channel function.
DCT reduces LTCC barium current (IBa,L) in reconstituted channel complexes
and mediates the fight or flight response in DCT knockout mice; yet the contri-
bution of DCT to ICa,L in native systems is unexplored. This study examines
the beat-to beat contribution of DCT to LTCC calcium homeostasis in native
cardiomyocytes.
Methods. We measured LTCC current with DCT co-expressed in cardiomyo-
cytes. We also heterologously co-expressed DCT and CaV1.2 constructs
with a stop corresponding to the predicted proteolytic cleavage site,
Cav1.2D1801, and a shorter deletion corresponding to well-studied construct,
Cav1.2D1733 along with CaVb2 subunits.
Results. DCT was found to inhibit IBa,L, but not ICa,L in cardiomyocytes.
DCT blocked IBa,L carried by both Cav1.2D1801 and Cav1.2D1733 in HEK
cells. However, DCT inhibited ICa,L carried by Cav1.2D1801 but not
Cav1.2D1733 channels. As CaM and DCT have adjoining interaction sites
on CaV1.2, we tested if exogenous CaM (CaMex) interferes with DCT current
inhibition in cardiomyocytes and HEK systems. CaMex relieved DCT block in
both systems and both channel variants. Addition of CaM1234 did not relieve
DCT current inhibition or have an additive effect. DCT did not alter voltage
dependence, or activation kinetics. The selective block of IBa,L suggested
that DCT activity may be relieved under conditions of elevated Ca.
Conclusions. DCT blockade of LTCC is apparent only when Ca is not the
charge carrier. Therefore, our data motivates the new hypothesis that DCT is
a native reverse use-dependent inhibitor of LTCC current.
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Regulation of CaV1.2 Channels by Sphingolipids and Cholesterol. Specific
Role of the Gamma Subunit
Anna Angelova, Naga Chalamalasetty, Roman Shirokov.
UMDNJ-NJMS, Newark, NJ, USA.Previoulsy (Biophys. Meetings 2010 and 2011), we showed that inactivation of
L-type Ca2þ channels containing the g1 subunit changes during cell cycle. The
half-inactivation voltage is very negative (in the 70 - 50 mV range) in cells
at the G1 phase, but also after serum starvation, or after the ER shock.
Here we report that the novel regulatory pathway is membrane-delimited be-
cause it depends on cholesterol and sphingolipids. Alterations of the membrane
lipid fluidity (e.g., addition of Triton X-100) affected inactivation regardless of
the g1 subunit. However, variousmanipulations withmembrane cholesterol, ce-
ramide, and/or shpingosine were efficient only when the g1 subunit was present.
Although tested positively in our experimental conditions, phosphoinositides, C-
8-ceramide-1-phosphate, sphingosine-1-phosphate, and glycosphingolipid
GM1 did not act specifically on inactivation with the g1 subunit.
When cholesterol was depleted from the membrane, or upon application of
sphingosine, ceramide-C2, or ceramide-C8, inactivation shifted to the 70 -
50 mV range. Isomers epi-cholesterol and dihydro-ceramide-C2 did not
act. Because ceramide and sphingosine strongly activate phosphatases PP1
and PP2A, phosphatase inhibitors calyculin A, or tautomycetin, were applied
in order to prevent a rapid current run-down. Thus, a role of phosphoryla-
tion-dependent pathways can be excluded as well.
We compared the membrane cholesterol content in cells at different cell-cycle
stages, but did not find any significant difference. However, the membrane con-
tents of sphingosine and ceramide are well known to change during cell cycle.
Therefore, we propose that the enhancement of inactivation of L-type channels
by the g1 subunit is dependent on sphingosine and ceramide. Possibly, the
sphingolipids interact directly with the subunit. The large scale of changes of
inactivation properties due to these interactions allows efficient spatiotemporal
tuning of functional availability of L-type Ca2þ channels.
Supported by R01MH079406.
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Neutralizing the Charges in a Voltage Sensor Repairs Gating Perturba-
tions in the Pore of CaV1.2
Stanislav Beyl, Katrin Depil, Annette Hohaus, Anna Stary-Weinzinger,
Eugen Timin, Steffen Hering.
Pharmacology and Toxicology, Vienna, Austria.
Voltage sensors initiate the closed - open transitions in the ion conducting pore.
Here we consecutively neutralized the charges of the four S4 segments (IS4-
IVS4) of CaV1.2. The channel construct lacking charges in IIS4 (IIS4N) con-
ducted barium currents. Surprisingly, charge neutralization accelerated channel
closure and diminished shifts of the activation curves also in S6 mutants (IS6:
G432W/IIS4N, IIS6: A780T/IIS4N, IIIS6: G1193T/IIS4N, IVS6: A1503G/
IIS4N). Such a rescue of S6-mediated gating perturbations is exemplified for
the IVS6 mutation A1503G. A1503G induced a22.651.2 mV shift of the ac-
tivation curve to the left that was diminished by charge neutralization in IIS4.
Gating disturbances induced by pore mutations upstream and downstream of
G432, G1193 and A1503 were unaffected.
Thermodynamic analysis reveals that seg-
ment IIS4 interacts (energetically cou-
pled) with a ring of small homologous
amino acids G432, A780, G1193 and
A1503 (G/A/G/A ring, Depil et al. 2011)
in all four pore forming S6 segments.
The research was funded by the Austrian
Science Fund (FWF): grant P22600-B12
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Temperature Effects on Pharmacologic Enhancement of L-Type Calcium
Current
Zhi Su, Xiaoqin Liu, Ruth L. Martin, Bryan F. Cox, Gary A. Gintant.
Abbott Laboratories, Abbot Park, IL, USA.
L-type calcium current (Cav1.2) plays a key role in modulation of multiple car-
diovascular functions. Therefore, Cav1.2 calcium current assay is useful in
screening discovery compounds for potential cardiovascular (CV) liabilities.
L-type calcium current itself is highly sensitive to temperature. However, it
is not known if drug effects on this current are influenced by temperature. Using
whole-cell voltage clamp techniques, we compared the effects of room (22-24
C) and physiological (37 C) temperatures on the current in the absence and
presence of a calcium current activator (TTYC) in CHO cells stably expressing
L-type calcium channels. Under our experiment conditions (2 mM [Ca2þ]o),
calcium current amplitude in CHO cells was increased approximately 4-fold
with warming from 24 to 37 C; the half maximal activation voltage (V1/2)
was shifted from 6.4 mV (24 C) to 17 mV (37 C). The calcium channel
activator TTYC (0.3 uM, Su et al. 2010) increased peak current by 925 10 %
